Jazz Pharmaceuticals plc (JAZZ) ownership: insiders 3% · institutions 104% (13F 2026-03-31). Insider activity, 90 days: Routine (11 sales, 0 open-market buys). 4 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| Vanguard | 6115451.00 | $1.16B | 9.4% | 2026-03-31 |
| BlackRock | 5591700.00 | $1.06B | 8.6% | 2026-03-31 |
| Capital Group | 2673376.00 | $505.40M | 4.1% | 2026-03-31 |
| LSV Asset Management | 2386840.00 | $451.23M | 3.7% | 2026-03-31 |
| FMR (Fidelity) | 2275762.00 | $430.23M | 3.5% | 2026-03-31 |
| Franklin Resources | 1958940.00 | $370.34M | 3.0% | 2026-03-31 |
| Dimensional Fund Advisors | 1895215.00 | $358.26M | 2.9% | 2026-03-31 |
| State Street | 1891646.00 | $357.62M | 2.9% | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-31 | |
| Sell | null | 2026-08-31 | |
| Sell | null | 2026-08-31 | |
| Sell | null | 2026-08-31 | |
| Sell | null | 2026-08-31 | |
| Sell | null | 2026-08-31 | |
| Sell | null | 2026-08-31 | |
| Sell | null | 2026-08-31 |
Back to JAZZ overview · JAZZ earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.